Company
Headquarters: Neve Ilan, Israel
Employees: 50
$185.0 Million
USD as of Jan. 1, 2026
| Company | Market Cap (USD) |
|---|---|
| Abbott | $216.15 B |
| Boston Scientific Corporation | $140.40 B |
| Stryker | $133.15 B |
| Medtronic | $123.20 B |
| Edwards Lifesciences Corporation | $50.10 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Neve Ilan, Israel.
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | $9.9 M |
| EBITDA | $-47,693,000 |
| Gross Profit TTM | $-6,592,000 |
| Profit Margin | -66.55% |
| Operating Margin | -438.67% |
| Quarterly Revenue Growth | 12.40% |
Nano-X Imaging Ltd. has the following listings and related stock indices.
Stock: NASDAQ: NNOX wb_incandescent